New partnerships for Check4Cancer

Joins up with Healix and amii

Jaskeet Briah
clock • 3 min read

Corporate healthcare trust provider, Healix, has partnered with Check4Cancer to offer employees diagnostic and faster access to cancer treatment.

Check4Cancer provides private health assessments to individuals and employers, offering services including cancer diagnostic and genetic investigations. The provider operates clinics across the UK that offer private screening services for various types of cancer. Employees of Healix's member companies can now access three diagnostic pathways for breast, skin and prostate cancer assessments without the need for a GP referral, via their Healix claims portal. Workers can also access diagnostic appointments with a consultant within a number of days from Check4Cancer's network of clinics, ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

Six in 10 adults would choose PMI as top employer-funded benefit
PMI

Six in 10 adults would choose PMI as top employer-funded benefit

27% have self-funded treatment over the past five years

Jaskeet Briah
clock 10 September 2025 • 3 min read
Perci Health appoints medical director to support expansion
PMI

Perci Health appoints medical director to support expansion

Launch of new specialist clinics

Jaskeet Briah
clock 04 September 2025 • 2 min read
Private healthcare admissions hit second highest level in Q1 2025
PMI

Private healthcare admissions hit second highest level in Q1 2025

Insured admissions remain stable

Jaskeet Briah
clock 02 September 2025 • 3 min read